Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression
Open Access
- 22 July 2020
- Vol. 12 (8), 2004
- https://doi.org/10.3390/cancers12082004
Abstract
Background: Cathepsin L (Ctsl) is a cysteine protease mainly located within the endosomal/lysosomal cell compartment. High expression of Ctsl indicates poor prognosis in human breast cancer. However, the cell type-specific Ctsl functions responsible for this association remain elusive. Methods: Because constitutive Ctsl−/− mice develop a complex phenotype, we developed a conditional model allowing for cell type-specific inactivation of Ctsl in mammary epithelium or myeloid cells in the transgenic mouse mammary tumor virus (MMTV)-polyoma middle T (PyMT) breast cancer model. Results: Ctsl ablation in mammary epithelial cells resulted in delayed initiation and end-stage of cancers. The latter displayed large dead cell areas. Inducible in vitro deletion of Ctsl in MMTV-PyMT-derived breast cancer cells revealed expansion of the acidic cell compartment, alteration of intracellular amino acid levels, and impaired mTOR signaling. In consequence, Ctsl-deficient cells exhibited slow growth rates and high apoptosis susceptibility. In contrast to Ctsl-deficient mammary epithelium, selective knockout of Ctsl in myeloid cells had no effects on primary tumors, but promoted lung metastasis formation. Conclusions: Our cell type-specific in vivo analysis provides strong evidence for a cancer cell-intrinsic, tumor-promoting role of Ctsl in primary breast cancer, whereas metastasis is negatively regulated by Ctsl expressed by bone marrow-derived cells.Funding Information
- Deutsche Forschungsgemeinschaft (Re1584/6-2, SFB 850 Z1, SFB 850 B7)
This publication has 56 references indexed in Scilit:
- Cathepsin S from both tumor and tumor‐associated cells promote cancer growth and neovascularizationInternational Journal of Cancer, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Protective role of cathepsin L in mouse skin carcinogenesisMolecular Carcinogenesis, 2011
- Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)ACS Medicinal Chemistry Letters, 2011
- Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptidesNeuropeptides, 2010
- IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasionGenes & Development, 2010
- Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermisOncogene, 2009
- Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T AntigenMicrobiology and Molecular Biology Reviews, 2009
- Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient miceTransgenic Research, 2007
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991